3Wu HY, Tomizawa K, Matsui H. Calpain-calcineurin signaling in the pathogenesis of calcium-dependent disorder[J]. Acta Med Okay- ama, 2007, 61(3): 123-137.
5Murphy RM, Snow RJ, Lamb GD. mu-Calpain and calpain-3 are not autolyzed with exhaustive exercise in humans[J]. Am J Physiol Cell Physiol, 2006, 290(1): C116-C122.
6Goll DE, Neti G, Mares SW, et al. Myofibrillar protein turnover: The proteasome and the calpains[J]. J Anim Sci, 2008, 86(14 Sup- pl): E19-E35.
7Smith IJ, Lecker SH, Hasselgren PO. Calpain activity and muscle wasting in sepsis[J]. Am J Physiol Endocrinol Metab, 2008, 295 (4) : E762-E771.
8Tidball JG, Spencer MJ. Expression of a ealpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuse[J]. J Physiol, 2002, 545(Pt 3): 819-- 828.
9Kang MY, Zhang Y, Matkovich SJ, et al. Receptor-independent cardiac protein kinase C activation by calpain-mediated truncation of regulatory domains[J]. Cire Res, 2010, 107(7): 903--912.
10Yoshikawa Y, Zhang GX, Obata K, et al. Cardioproteetive effects of a novel calpain inhibitor SNJ-1945 for reperfusion injury after car-dioplegic cardiac arrest[J]. Am J Physiol Heart Circ Physiol, 2010, 298(2) : H643-H651.
